124 related articles for article (PubMed ID: 11019422)
1. [Effect of probucol on cardiac electrophysiology in anginal patients with hyperlipidemia and diabetes mellitus type II].
Anikin VV; Savin VV; Lupanov VP; Razygraev RA
Ter Arkh; 2000; 72(8):28-30. PubMed ID: 11019422
[TBL] [Abstract][Full Text] [Related]
2. [Hypolipidemic effects of alisat and lipostabil in patients with diabetes mellitus].
Mel'chinskaia EN; Gromnatskiĭ NI; Kirichenko LL
Ter Arkh; 2000; 72(8):57-8. PubMed ID: 11019431
[TBL] [Abstract][Full Text] [Related]
3. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
[TBL] [Abstract][Full Text] [Related]
4. [Antioxidant probucol: effects on free radical lipid peroxidation, blood rheology and course of angina pectoris].
Zakirova AN; Shamaev AG; Mirionkova NA
Ter Arkh; 1998; 70(1):29-32. PubMed ID: 9532648
[TBL] [Abstract][Full Text] [Related]
5. Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk.
Velussi M
Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):29-35. PubMed ID: 12125227
[TBL] [Abstract][Full Text] [Related]
6. Analysis of serum lipids and lipoproteins in Ethiopian diabetic patients.
Seyoum B; Abdulkadir J; Berhanu P; Feleke Y; Mengistu Z; Worku Y; Ayana G
Ethiop Med J; 2003 Jan; 41(1):1-8. PubMed ID: 12764995
[TBL] [Abstract][Full Text] [Related]
7. [Acarbose (glucobai) effects on lipid metabolism in patients with non-insulin dependent diabetes mellitus].
Rosliakova LV; Roĭtman AP; Ametov AS; Dolgov VV
Ter Arkh; 2000; 72(8):54-6. PubMed ID: 11019430
[TBL] [Abstract][Full Text] [Related]
8. [Features of angina pectoris in patients with non-insulin-dependent diabetes mellitus (NIDDM)].
Anikin VV; Savin VV
Klin Med (Mosk); 1999; 77(12):37-40. PubMed ID: 10684214
[TBL] [Abstract][Full Text] [Related]
9. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
Castaño G; Menéndez R; Más R; Amor A; Fernández JL; González RL; Lezcay M; Alvarez E
Int J Clin Pharmacol Res; 2002; 22(3-4):89-99. PubMed ID: 12837046
[TBL] [Abstract][Full Text] [Related]
10. Effects of rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.
Chu CS; Lee KT; Lee MY; Su HM; Voon WC; Sheu SH; Lai WT
Am J Cardiol; 2006 Mar; 97(5):646-50. PubMed ID: 16490430
[TBL] [Abstract][Full Text] [Related]
11. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
Udawat H; Goyal RK
Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472
[TBL] [Abstract][Full Text] [Related]
12. [Specific features of lipid atherogenic modification in patients with ischemic heart disease and diabetes mellitus].
Syrkin AL; Azizova OA; Drinitsina SV; Solovi'eva NP; Frenkel' EE; Savchenkova AP; Kliuchnikova TI
Klin Med (Mosk); 2001; 79(4):25-9. PubMed ID: 11496733
[TBL] [Abstract][Full Text] [Related]
13. Pravastatin has an additional depressor effect in patients undergoing long-term treatment with antihypertensive drugs.
Ikeda T; Sakurai J; Nakayama D; Takahashi Y; Matsuo K; Shibuya Y; Gomi T; Moriya H; Kobayashi S
Am J Hypertens; 2004 Jun; 17(6):502-6. PubMed ID: 15177522
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin or fenofibrate on post-prandial lipaemia in type 2 diabetic patients with hyperlipidaemia.
Iovine C; Lilli S; Gentile A; Patti L; Di Marino L; Cipriano P; Riccardi G; Rivellese AA
Eur J Clin Invest; 2006 Aug; 36(8):560-5. PubMed ID: 16893378
[TBL] [Abstract][Full Text] [Related]
15. [Non-alcoholic hepatic steatosis: the role of policosanols in associated hyperlipidemia].
Musto D; Martorelli L; Russo M; Esposito G; Amato MR; Esposito P; Riegler G
Minerva Gastroenterol Dietol; 2010 Dec; 56(4):389-95. PubMed ID: 21139538
[TBL] [Abstract][Full Text] [Related]
16. Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes.
Thomason MJ; Colhoun HM; Livingstone SJ; Mackness MI; Betteridge DJ; Durrington PN; Hitman GA; Neil HA; Fuller JH;
Diabet Med; 2004 Aug; 21(8):901-5. PubMed ID: 15270795
[TBL] [Abstract][Full Text] [Related]
17. [Disorders of lipid metabolism in 3 patients with diabetes mellitus type 2].
Wolffenbuttel BH; Huijberts MS
Ned Tijdschr Geneeskd; 2001 Apr; 145(16):761-5. PubMed ID: 11346911
[TBL] [Abstract][Full Text] [Related]
18. [Effect of long-term cardiac training on lipids concentration in patients with chronic heart ischemic disease treated with simvastatin].
Kałka D; Sobieszczańska M; Kopka L; Marciniak W; Zawadzka-Bartczak E; Bak A; Popielewicz-Kautz A; Korzeniowska J; Janczak J; Adamus J
Pol Merkur Lekarski; 2007 Feb; 22(128):101-6. PubMed ID: 17598652
[TBL] [Abstract][Full Text] [Related]
19. The influence of low-dose atorvastatin on lipid levels and endothelial vascular function in patients with significant coronary artery stenosis.
Kuryata OV; Yegorova YV
Kardiol Pol; 2006 Jan; 64(1):44-8; discussion 49-50. PubMed ID: 16444629
[TBL] [Abstract][Full Text] [Related]
20. Post-marketing surveillance of probucol (Sinlestal) in Japan.
Kosasayama A; Yoshida M; Okada S
Artery; 1992; 19(3):147-61. PubMed ID: 1637256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
